Russell Little, APN | |
175 Cross Keys Rd, Bldg. 300a, Berlin, NJ 08009-9263 | |
(856) 767-0077 | |
(856) 767-6102 |
Full Name | Russell Little |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 175 Cross Keys Rd, Berlin, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336518778 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | 26NJ00589900 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Russell Little, APN 175 Cross Keys Rd, Bldg. 300a, Berlin, NJ 08009-9263 Ph: (856) 767-0077 | Russell Little, APN 175 Cross Keys Rd, Bldg. 300a, Berlin, NJ 08009-9263 Ph: (856) 767-0077 |
News Archive
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Although the U.S. Army suicide rate is known to have risen sharply over the past decade, information about medically documented, non-fatal suicidal behaviors is far more limited. According to findings published in Psychiatry: Interpersonal & Biological Processes incidence rates of suicide ideation and suicide attempts increased annually among Soldiers during the years 2004-2009.
Two-thirds of people with severe and otherwise untreatable epilepsy were completely cured of their frequent seizures after undergoing neurosurgery at the University of California, San Francisco Medical Center, according to a new study that examined 143 of these patients two years after their operations.
Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.
A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.
› Verified 2 days ago
Joanne M Tobiasz, APN-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 175 Cross Keys Rd Ste 300a, Berlin, NJ 08009 Phone: 856-767-0077 | |
Karen Gudrun Barton, RNC, MS, CRNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 181 W White Horse Pike Ste 100, Berlin, NJ 08009 Phone: 856-767-3234 Fax: 856-767-3518 | |
Ms. Kelly Barranger, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 175 Cross Keys Rd Ste 300a, Berlin, NJ 08009 Phone: 856-767-0077 | |
Kathryn L. D'angelo, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 181 W White Horse Pike, Suite 100, Berlin, NJ 08009 Phone: 856-767-3234 Fax: 856-767-3518 | |
Ms. Heather Elizabeth Fean, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 181 W White Horse Pike, Suite 100, Berlin, NJ 08009 Phone: 856-767-6670 Fax: 856-767-3518 | |
Mrs. Chinyere Evangeline Ubah, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Townsend Ave, Berlin, NJ 08009 Phone: 609-534-9196 |